The company’s Chief Financial Officer (CFO) Erik Björk resigned on February 7, 2019.
Erik Björk, who took on the position as CFO in January 2018, leaves the company at his own request. He will remain in the company for a transitional period.
Lotta Ferm will assume the role as interim CFO as of March 1st. Recruitment of a permanent CFO is ongoing.
Photo of Erik Björk: Medivir